Stock Research: Equasens

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Equasens

ENXTPA:PHA FR0012882389
78
  • Value
    73
  • Growth
    46
  • Safety
    Safety
    42
  • Combined
    57
  • Sentiment
    75
  • 360° View
    360° View
    78
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Equasens SA, formerly Pharmagest Interactive SA, is a France-based company specializing in software solutions for healthcare. It operates in the healthcare IT sector, providing software for pharmacies, hospitals, and other health establishments. Its main region of operation is France. In the last fiscal year, the company had a market cap of $887 million, profits of $154 million, and revenue of $224 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 78 (better than 78% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Equasens are very positive. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Equasens. The consolidated Sentiment Rank has a good rank of 75, which means that professional investors are more optimistic about the stock than for 75% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 73 or better than 73% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 42, meaning that the share price of Equasens is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 46. ...read more

more
Index
CAC All
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
42 65 61 50
Growth
46 31 31 19
Safety
Safety
73 70 67 53
Sentiment
75 98 92 34
360° View
360° View
78 87 79 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
67 95 82 100
Opinions Change
15 50 50 50
Pro Holdings
n/a 77 80 1
Market Pulse
65 83 77 20
Sentiment
75 98 92 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
42 65 61 50
Growth
46 31 31 19
Safety Safety
73 70 67 53
Combined
57 65 51 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
50 67 56 56
Price vs. Earnings (P/E)
25 34 38 38
Price vs. Book (P/B)
50 50 46 38
Dividend Yield
73 84 86 68
Value
42 65 61 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
39 72 49 42
Profit Growth
47 8 46 53
Capital Growth
50 82 35 38
Stock Returns
54 31 17 15
Growth
46 31 31 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
63 57 51 41
Refinancing
38 31 37 33
Liquidity
86 88 92 79
Safety Safety
73 70 67 53

Similar Stocks

Discover high‑ranked alternatives to Equasens and broaden your portfolio horizons.

Rubis

ENXTPA:RUI
Country: France
Industry: Gas Utilities
Size: Medium
Full Stock Analysis

Savencia

ENXTPA:SAVE
Country: France
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Societe Generale

ENXTPA:GLE
Country: France
Industry: Diversified Banks
Size: Medium
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.